Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 15Gynecologic 2Gastrointestinal 2Thoracic 1Sarcoma 1Lymphoid 1Head & Neck 1Genitourinary 1Dermatologic 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 4Leukemia, Myeloid, Acute 3Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Leukemia 2Waldenstrom Macroglobulinemia 1Neurologic Manifestations 1Myelodysplastic-Myeloproliferative Diseases 1Multiple Myeloma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Prolymphocytic 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Graft vs Host Disease 1Chromosome 17 deletion 1Cardiovascular Diseases 1COVID-19 1Breast Neoplasms 1

Interventions

Cyclophosphamide 10pembrolizumab 9Therapeutics 8Flow Cytometry 6Radiotherapy 5Gemcitabine 5Blood Specimen Collection 5Surveys and Questionnaires 4Sirolimus 4Psychiatric Rehabilitation 4Peripheral Blood Stem Cell Transplantation 4Paclitaxel 4Nivolumab 4Methods 4Ipilimumab 4Filgrastim 4Exercise 4Drug Therapy 4Doxorubicin 4Capecitabine 4copanlisib 3aldesleukin 3Rituximab 3Polymerase Chain Reaction 3Immunologic Techniques 3Immunoglobulin G 3Immunoenzyme Techniques 3Fluorodeoxyglucose F18 3Early Intervention, Educational 3Disulfides 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Breast Neoplasms × Atorvastatin × Lymphoid × Clear all
NCT01988571 2022-01-04

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

Wake Forest University Health Sciences

Phase 2 Completed
279 enrolled 26 charts
BreastLymphoid

Breast Neoplasms, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡